In 2024, EP Pharmaceuticals OÜ had revenue of 68.5 thousand EUR and profit of 69.2 thousand EUR. Beneficial owners: Giacomo Spignoli.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 68,5k € -48.3% | 132,4k € +166.2% | 49,7k € |
Profit | 69,2k € -47.3% | 131,2k € +172.5% | 48,1k € |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | 250,9k € +40.1% | 179,1k € +272.1% | 48,1k € |
Employees | - | - | - |
Overall rating | B+81/100 |
Financial health | 100/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Authorised representative | - | |||
| - | Board member | - |
In 2024, EP Pharmaceuticals OÜ had revenue of 68 504 EUR and profit of 69 172 EUR. Compared to previous year, revenue decreased by 48.3%. View full financial report →
The beneficial owners of EP Pharmaceuticals OÜ are Giacomo Spignoli. View ownership details →
No, EP Pharmaceuticals OÜ does not have an active VAT number and is not registered as a VAT payer.
EP Pharmaceuticals OÜ was founded on March 16, 2022. The company has been operating for 4 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 4 years | 4843 - 4847 | 29% | |
Net revenue | 68 504,00 € | 1911 - 1915 | 72% | |
Profit | 69 172,00 € | 717 - 721 | 89% | |
Equity | 250 936,00 € | 982 - 986 | 85% | |
Profitability | 101.0% | - | 90% | |
Registered capital | 2500,00 € | - | 40% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Giacomo Spignoli | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Giacomo Spignoli | IT | - |